To see the other types of publications on this topic, follow the link: Disrimination in medical care.

Journal articles on the topic 'Disrimination in medical care'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Disrimination in medical care.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Zuidema, George D. "Medical Care, Medical Costs." Plastic and Reconstructive Surgery 81, no. 4 (April 1988): 637. http://dx.doi.org/10.1097/00006534-198804000-00037.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Terris, Milton. "Medical Care." Journal of Public Health Policy 12, no. 1 (1991): 28. http://dx.doi.org/10.2307/3342774.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tierney, William M., Morris Weinberger, John Ayanian, Audrey Burnam, Jos?? J. Escarce, Ron D. Hays, Ronnie D. Horner, et al. "Medical Care." Medical Care 39, no. 1 (January 2001): 1–3. http://dx.doi.org/10.1097/00005650-200101000-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mchorney, Colleen A., and Carol M. Ashton. "Medical Care." Medical Care 41, no. 7 (July 2003): 775–76. http://dx.doi.org/10.1097/00005650-200307000-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Feigin, Joel. "Medical Care Management." Allergy and Asthma Proceedings 17, no. 6 (November 1, 1996): 359–61. http://dx.doi.org/10.2500/108854196778606428.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Miura, Hisayuki. "Home medical care." Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 51, no. 2 (2014): 117–19. http://dx.doi.org/10.3143/geriatrics.51.117.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ilyas, Muhammad, Muhammad Zahid, and Chris Roseveare. "Acute medical care." Clinical Medicine 10, no. 3 (June 2010): 304.1–304. http://dx.doi.org/10.7861/clinmedicine.10-3-304.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

MacStravic, Robin Scott. "Marketing Medical Care." Health Marketing Quarterly 2, no. 2-3 (April 1985): 157–70. http://dx.doi.org/10.1300/j026v02n02_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Carlson, Lisa. "Spectator Medical Care." Physician and Sportsmedicine 20, no. 1 (January 1992): 141–44. http://dx.doi.org/10.1080/00913847.1992.11710237.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Parry, K. M. "Auditing medical care." Medical Education 24, no. 1 (January 1990): 1–2. http://dx.doi.org/10.1111/j.1365-2923.1990.tb02427.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

&NA;. "MEDICAL CARE CAPSULE." Medical Care 24, no. 3 (March 1986): 276–78. http://dx.doi.org/10.1097/00005650-198603000-00009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

&NA;. "MEDICAL CARE CAPSULE." Medical Care 24, no. 6 (June 1986): 561–63. http://dx.doi.org/10.1097/00005650-198606000-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

&NA;. "MEDICAL CARE CAPSULE." Medical Care 23, no. 4 (April 1985): 372–74. http://dx.doi.org/10.1097/00005650-198504000-00009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

&NA;. "MEDICAL CARE CAPSULE." Medical Care 24, no. 8 (August 1986): 781–84. http://dx.doi.org/10.1097/00005650-198608000-00013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

&NA;. "MEDICAL CARE CAPSULE." Medical Care 24, no. 10 (October 1986): 967–68. http://dx.doi.org/10.1097/00005650-198610000-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

&NA;. "MEDICAL CARE CAPSULE." Medical Care 23, no. 6 (June 1985): 842–43. http://dx.doi.org/10.1097/00005650-198506000-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

&NA;. "MEDICAL CARE CAPSULE." Medical Care 23, no. 7 (July 1985): 933–34. http://dx.doi.org/10.1097/00005650-198507000-00008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

&NA;. "MEDICAL CARE CAPSULE." Medical Care 23, no. 9 (September 1985): 1120–21. http://dx.doi.org/10.1097/00005650-198509000-00009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

&NA;. "MEDICAL CARE CAPSULE." Medical Care 23, no. 10 (October 1985): 1219. http://dx.doi.org/10.1097/00005650-198510000-00012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Teschler, H. "Integrated Medical Care." Pneumologie 59, no. 3 (March 2005): 201–3. http://dx.doi.org/10.1055/s-2004-830157.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Jones, James W., and Laurence B. McCullough. "Medical care manifesto." Journal of Vascular Surgery 55, no. 6 (June 2012): 1812–13. http://dx.doi.org/10.1016/j.jvs.2012.01.076.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

&NA;. "MEDICAL CARE CAPSULE." Medical Care 29, no. 9 (September 1991): 937–38. http://dx.doi.org/10.1097/00005650-199109000-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

&NA;. "MEDICAL CARE CAPSULE." Medical Care 25, no. 3 (March 1987): 265–66. http://dx.doi.org/10.1097/00005650-198703000-00012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

&NA;. "MEDICAL CARE CAPSULE." Medical Care 25, no. 5 (May 1987): 452–53. http://dx.doi.org/10.1097/00005650-198705000-00008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

&NA;. "MEDICAL CARE CAPSULE." Medical Care 25, no. 6 (June 1987): 579–80. http://dx.doi.org/10.1097/00005650-198706000-00017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

&NA;. "MEDICAL CARE CAPSULE." Medical Care 25, no. 9 (September 1987): 924–25. http://dx.doi.org/10.1097/00005650-198709000-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

&NA;. "MEDICAL CARE CAPSULE." Medical Care 25, Supplement (September 1987): 924–25. http://dx.doi.org/10.1097/00005650-198709001-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

&NA;. "MEDICAL CARE CAPSULE." Medical Care 25, no. 10 (October 1987): 1015–16. http://dx.doi.org/10.1097/00005650-198710000-00011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

&NA;, &NA;. "Medical Care Capsule." Medical Care 26, no. 2 (February 1988): 217–19. http://dx.doi.org/10.1097/00005650-198802000-00012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

LAVE, JUDITH R., CHRIS L. PASHOS, GERARDF ANDERSON, DAVID BRAILER, THOMAS BUBOLZ, DOUGLAS CONRAD, DEBORAH A. FREUND, et al. "Costing Medical Care." Medical Care 32, Supplement (July 1994): JS90. http://dx.doi.org/10.1097/00005650-199407001-00007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Shirley, P. "Prehospital medical care." BMJ 321, no. 7255 (July 22, 2000): 2. http://dx.doi.org/10.1136/bmj.321.7255.s2-7255.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

MacLean, JA. "Team Medical Care." Scottish Medical Journal 55, no. 2 (May 2010): 19–21. http://dx.doi.org/10.1258/rsmsmj.55.2.19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Smith, Mark A. H. "Limiting Medical Care." Southern Medical Journal 79, no. 11 (November 1986): 1464. http://dx.doi.org/10.1097/00007611-198611000-00043.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Kavanagh, Kevin T., and Nellie P. Tate. "Indigent Medical Care:." Journal of Health & Social Policy 2, no. 1 (December 13, 1990): 1–7. http://dx.doi.org/10.1300/j045v02n01_01.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Steffen, Grant E. "Quality Medical Care." JAMA 260, no. 1 (July 1, 1988): 56. http://dx.doi.org/10.1001/jama.1988.03410010064036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Taleb, Rim. "Beyond Medical Care." American Annals of the Deaf 160, no. 1 (2015): 7–8. http://dx.doi.org/10.1353/aad.2015.0011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Faruque, A. S. G., and Abu Eusof. "Medical Care Utilization." Tropical Doctor 16, no. 2 (April 1986): 87–89. http://dx.doi.org/10.1177/004947558601600217.

Full text
Abstract:
This paper describes the use-pattern of medical care prior to death caused by cholera outbreaks in rural Bangladesh. In nine rural communities 92 acute diarrhoeal deaths were recorded. These mainly occurred within 24 hours or less of diarrhoea onset, and were time-clustered. An on-the-spot stool culture survey of active cases confirmed cholera cases. In 50% of deaths, diarrhoea onset occurred between midnight and 9 am. Fifty-one percent of the fatalities had been treated earlier by village practitioners, another 20% had been attended by qualified doctors, and 8% had had no medical care. Oral rehydration therapy alone had been used in 29 cases, but 26 died within 24 hours. Of 43 persons who received intravenous therapy, oral rehydration and antibiotics, 21 (45%) died within 24 hours and 12 (28%) after 48 hours. Seventeen deceased had received no rehydration therapy. Early and adequate fluid therapy is required for optimal rehydration. Training of community people and health personnel, along with resources mobilization, will save lives by preventing unnecessary dehydration deaths.
APA, Harvard, Vancouver, ISO, and other styles
38

DUHAN, PHYLLIS COULTER. "Medical Day Care." Nursing Management (Springhouse) 18, no. 11 (November 1987): 51???57. http://dx.doi.org/10.1097/00006247-198711000-00016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

McGregor, M. "Medical care delivery." Canadian Medical Association Journal 173, no. 12 (December 6, 2005): 1486. http://dx.doi.org/10.1503/cmaj.1050188.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Burstein, David S. "Conflating Medical Care With Patient Care." Journal of Graduate Medical Education 9, no. 5 (October 1, 2017): 671. http://dx.doi.org/10.4300/jgme-d-17-00458.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Sharma, Kiran, David Oliver, Gillian Blatchford, Pauline Higginbottom, and Vera Khan. "Medical Care in Hospice Day Care." Journal of Palliative Care 9, no. 3 (September 1993): 42–43. http://dx.doi.org/10.1177/082585979300900301.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

LIGHT, DONALD W. "Medical Care Capsule Primary Managed Care." Medical Care 34, no. 9 (September 1996): 985. http://dx.doi.org/10.1097/00005650-199609000-00009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Winkelstein, W. "Medical care is not health care." JAMA: The Journal of the American Medical Association 269, no. 19 (May 19, 1993): 2504. http://dx.doi.org/10.1001/jama.269.19.2504.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Winkelstein, Warren. "Medical Care Is Not Health Care." JAMA: The Journal of the American Medical Association 269, no. 19 (May 19, 1993): 2504. http://dx.doi.org/10.1001/jama.1993.03500190046021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Hida, Nobuo. "Advanced Medical Care and Medical Ethics." TRENDS IN THE SCIENCES 7, no. 5 (2002): 55–58. http://dx.doi.org/10.5363/tits.7.5_55.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Himsworth, R. L. "AMERICA'S DOCTORS, MEDICAL SCIENCE, MEDICAL CARE." Lancet 329, no. 8542 (May 1987): 1136–37. http://dx.doi.org/10.1016/s0140-6736(87)91686-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Smythe, Maureen A., Prakash P. Shah, Terry L. Spiteri, Richard L. Lucarotti, and Robert L. Begle. "Pharmaceutical Care in Medical Progressive Care Patients." Annals of Pharmacotherapy 32, no. 3 (March 1998): 294–99. http://dx.doi.org/10.1345/aph.17068.

Full text
Abstract:
OBJECTIVE: To develop, implement, and assess the outcomes of a system for providing pharmaceutical care to medical progressive care patients. METHODS: A system for providing pharmaceutical care was developed and implemented for an 8-week period beginning in June 1995. Both patient care outcomes and drug therapy cost change from the intervention period were compared with those of an 8-week baseline period. Variables compared included unit length of stay, hospital length of stay, transfers to the intensive care unit, readmissions, and adverse drug reactions requiring treatment. Differences between periods for these variables were assessed by using χ2 tests and t-tests with α set at p less than 0.05. The clinical significance of the interventions were assessed independently by four physicians: two intensivists and two internists. The total drug therapy cost change from the intervention period was calculated as follows: total cost avoidance from individual recommendations subtracted from the total cost incurred from individual recommendations. RESULTS: The pharmacist evaluated 152 patients during the intervention period. A total of 235 pharmacotherapy recommendations were made on 103 patients, of whom 86.4% were accepted. Significantly fewer adverse drug reactions (ADRs) received treatment during the intervention period (p = 0.027). The mean unit length of stay was lower during the intervention period (4.8 ± 3.7 d) than during the baseline period (6.0 ± 5.6 d); however, this difference was not significant (p = 0.053). Individual physician assessment of the pharmacists' recommendations revealed that 75.8% were considered somewhat significant, significant, or very significant. The total drug therapy cost change from the intervention period was –$6534.53. The projected annual drug therapy cost reduction from this study is $42 474.45. CONCLUSIONS: The provision of pharmaceutical care to medical progressive care patients was associated with a substantial decrease in drug therapy cost and a decrease in the number of ADRs that required treatment. OBJETIVO: Desarrollar, implementar, y evaluar los resultados de un sistema que provee atención farmacéutica a pacientes en una unidad de cuidado intensivo. MÉTODOS: Un sistema para la provisión de atención farmacéutica fue desarrollado e implementado por un período de 8 semanas comenzando en junio de 1995. Se compararón los resultados clínicos de los pacientes y el costo de los cambios en terapia antes de implementarse el sistema 8 semanas antes y luego de su implementación por un período de 8 semanas. Las variables que se compararón incluyen duración de estadía en el hospital y en la unidad de cuidado intensivo, traslados a la unidad de cuidado intensivo, re-admisiones, y reacciones adversas que requirieron tratamiento. La diferencia entre las variables se analizó usando la pruebas estadísticas de χ2 y de t-test con un alpha de p < 0.05. El significado clínico de las intervenciones hechas por el farmacéutico fue evaluado individualmente por cuatro de los médicos: dos internistas y dos especialistas en cuidado intensivo. El costo total de los cambios en la terapia durante el período de estudio se calculó de la siguiente manera: el costo total ahorrado como consequencia de las recomendaciones individuales del farmacéutico menos el costo total incurrido como consequencia de las recomendaciones individuales del farmacéutico. RESULTADOS: Un total de 152 pacientes fueron evaluados por el farmacéutico durante el período de estudio. Se hicierón 235 recomendaciones farmacoterapéuticas en 103 pacientes, de las cuales 86.4% fueron aceptadas por los médicos. Durante el período de estudio hubieron muchas menos reacciones adversas comparadas con las que ocurrierón antes del estudio (p = 0.027). La unidad promedio de estadía en el hospital fue menor durante el período de intervención (4.8 ± 3.7 d) que durante el período antes de la intervención (6.0 ± 5.6 d); sin embargo, esta diferencia no fue estadistícamente significativa (p = 0.053). Las evaluaciones individuales de las recomendaciones de los farmacéuticos por parte de los médicos, reveló que 75.8% de las recomendaciones fueron catalogadas como algo significativas, significativas, o muy significativas. El total del costo de la terapia fue de $6534.53 menos que antes de la intervención. El ahorro anual proyectado se estimó en $42 474.45. CONCLUSIONES: La provisión de atención farmacéutica en una unidad de cuidado intensivo fue asociada con una baja en el costo de la terapia con medicamentos y en el número de reacciones adversas que necesitarón tratamiento. INTRODUCTION: Développer un système de soins pharmaceutiques pour une unité de soins progressifs, de le mettre en application, et d'en évaluer l'efficacité. MÉTHODES: Le système a été mis en application pour une période de 8 semaines commençant en juin 1995. Il consistait en une évaluation systématique du patient et de sa médication, de même que de discussions au sein de l'équipe multidiciplinaire. Les 8 semaines précédant la mise en application du système, alors que les services pharmaceutiques étaient de nature plus traditionnels, ont servi de point de comparaison. Les variables comparées incluaient la durée du séjour à l'unité de soins, la durée du séjour hospitalier, les transferts vers les soins intensifs, les ré-admissions, et les réactions adverses nécessitant un traitement. Les différences avant/après ont été évaluées par le test du χ2 ou le test de t de Student avec un alpha de p < 0.05. La signification clinique des interventions a été évaluée de façon indépendante par quatre médecins: deux intensivistes et deux internistes. Les coûts nets générées par ces interventions ont été evaluées en soustrayant les coûts générés par les interventions des économies réalisées par celles-ci. RÉSULTATS: Le pharmacien a évalué 152 patients durant la période d'intervention. Un total de 235 recommandations pharmaceutiques ont été faites pour 103 patients; 86.4% de celles-ci ont été acceptées. Moins de réactions adverses ont nécessité un traitement durant l'intervention (p = 0.027). La durée moyenne d'un séjour à l'unité de soins était moins longue (4.8 ± 3.7 j vs. 6.0 ± 5.6 j); mais cette différence n'était pas statistiquement significative (p = 0.053). l'évaluation qu'ont faite les médecins des recommandations du pharmacien révèle que 75.8% des interventions étaient considérées quelque peu significatives, significatives, ou très significatives. Le changement de coûts a atteint -$6534.53, ce qui représente des économies annuelles de $42 474.45. CONCLUSIONS: Des soins pharmaceutiques à des patients d'une unité de soins progressifs ont été associés à de substantielles réductions dans le coût de la thérapie et une réduction des réactions adverses nécessitant un traitement.
APA, Harvard, Vancouver, ISO, and other styles
48

Kodama, Yasushi, and Kurokawa Kiyoshi. "Safety in Medical Care." TRENDS IN THE SCIENCES 5, no. 2 (2000): 6–13. http://dx.doi.org/10.5363/tits.5.2_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Fujimasa, Iwao. "Nanotechnology and Medical Care." TRENDS IN THE SCIENCES 7, no. 8 (2002): 37–40. http://dx.doi.org/10.5363/tits.7.8_37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Legters, Llewellyn J. "Medical Care of Refugees." American Journal of Tropical Medicine and Hygiene 39, no. 2 (August 1, 1988): 223–24. http://dx.doi.org/10.4269/ajtmh.1988.39.223.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography